Article Information
History
- May 6, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ntombikayise Xelwa1,
- Previn Naicker2,
- Jones Omoshoro-Jones1,3,
- John Devar1,3,
- Martin Smith1,3,
- Geoffrey Candy1,
- Tanya Nadine Augustine4 and
- Ekene Emmanuel Nweke1,5,*
- 1Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193. South Africa
- 2Council for Scientific and Industrial Research, Pretoria. South Africa
- 3Hepatopancreatobiliary (HPB) Surgery, Chris Hani Baragwanath Academic Hospital, Johannesburg. South Africa
- 4School of Anatomical Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193. South Africa
- 5Department of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Florida, Roodepoort, South Africa
- ↵*Corresponding author: Nweke E.E, Department of Surgery, University of the Witwatersrand, 7 York Road Parktown, Johannesburg, 2193 South Africa. Email: ekene.nweke{at}wits.ac.za. Tel: +2711 717 2801
Posted May 06, 2024.
The combination of SPP1 knockdown and gemcitabine treatment enhances apoptosis and reduces invasiveness of pancreatic cancer cells
